{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:24:31Z","timestamp":1787858671698,"version":"build-2784847793"},"reference-count":73,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01AI033993"],"award-info":[{"award-number":["R01AI033993"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM037537"],"award-info":[{"award-number":["R01GM037537"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM147039"],"award-info":[{"award-number":["R35GM147039"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.mcpro.2025.100971","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T19:22:12Z","timestamp":1744658532000},"page":"100971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Identification of Post-translationally Modified MHC Class I\u2013Associated Peptides as Potential Cancer Immunotherapeutic Targets"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4561-9838","authenticated-orcid":false,"given":"Keira E.","family":"Mahoney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4399-8283","authenticated-orcid":false,"given":"Larry","family":"Reser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Virginia","family":"Ruiz Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5262-7241","authenticated-orcid":false,"given":"Jennifer G.","family":"Abelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5750-3539","authenticated-orcid":false,"given":"Jeffrey","family":"Shabanowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2815-6368","authenticated-orcid":false,"given":"Donald F.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2382-5067","authenticated-orcid":false,"given":"Stacy A.","family":"Malaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcpro.2025.100971_bib1","series-title":"Janeway\u2019s Immunobiology","author":"Murphy","year":"2008"},{"key":"10.1016\/j.mcpro.2025.100971_bib2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM200009073431006","article-title":"The HLA system","volume":"343","author":"Klein","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcpro.2025.100971_bib3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mcpro.2025.100971_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/cancers12030535","article-title":"Mass spectrometry-based identification of MHC-associated peptides","volume":"12","author":"Kote","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.mcpro.2025.100971_bib5","series-title":"The HLA FactsBook","author":"Marsh","year":"2000"},{"key":"10.1016\/j.mcpro.2025.100971_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/eji.1830170312","article-title":"Sequences and repertoire of the human T cell receptor \u03b1 and \u03b2 chain variable region genes in thymocytes","volume":"17","author":"Kimura","year":"1987","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.mcpro.2025.100971_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0161-5890(02)00096-2","article-title":"Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire","volume":"39","author":"Engelhard","year":"2002","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.mcpro.2025.100971_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-018-0001-y","article-title":"The full spectrum of human naive T cells","volume":"18","author":"van den Broek","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mcpro.2025.100971_bib9","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.4049\/jimmunol.169.7.3760","article-title":"Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo","volume":"169","author":"Grayson","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.mcpro.2025.100971_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1152\/advan.00066.2013","article-title":"T cell responses: naive to memory and everything in between","volume":"37","author":"Pennock","year":"2013","journal-title":"Adv. Physiol. Educ."},{"key":"10.1016\/j.mcpro.2025.100971_bib11","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1172\/JCI130562","article-title":"Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA","volume":"130","author":"Holland","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mcpro.2025.100971_bib12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41587-022-01567-w","article-title":"Facile repurposing of peptide-MHC-restricted antibodies for cancer immunotherapy","volume":"41","author":"Yang","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mcpro.2025.100971_bib13","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.2020010477","article-title":"Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody","volume":"138","author":"Augsberger","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.mcpro.2025.100971_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.mcpro.2025.100971_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0787-5","article-title":"Tumor neoantigens: from basic research to clinical applications","volume":"12","author":"Jiang","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mcpro.2025.100971_bib16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2025.100971_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000262","article-title":"MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma","volume":"8","author":"Engelhard","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mcpro.2025.100971_bib18","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/cas.16118","article-title":"Emerging potential of immunopeptidomics by mass spectrometry in cancer immunotherapy","volume":"115","author":"Minegishi","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.mcpro.2025.100971_bib19","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1038\/ncomms13404","article-title":"Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry","volume":"7","author":"Bassani-Sternberg","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.100971_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3389\/fcell.2020.00728","article-title":"Progress in neoantigen targeted cancer immunotherapies","volume":"8","author":"Han","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.mcpro.2025.100971_bib21","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1158\/1078-0432.CCR-13-2697","article-title":"T-cell responses to oncogenic Merkel cell polyomavirus proteins distinguish patients with Merkel cell carcinoma from healthy donors","volume":"20","author":"Lyngaa","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mcpro.2025.100971_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cell.2020.08.053","article-title":"A phase Ib trial of personalized neoantigen therapy plus anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or Bladder cancer","volume":"183","author":"Ott","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.100971_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","article-title":"The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy","volume":"40","author":"Ardito","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.mcpro.2025.100971_bib24","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006098","article-title":"Signal transduction in cancer","volume":"5","author":"Sever","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.mcpro.2025.100971_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006889","article-title":"The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles","volume":"11","author":"Molvi","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mcpro.2025.100971_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.mcpro.2025.100971_bib27","article-title":"Exploring the dynamic landscape of immunopeptidomics: unravelling posttranslational modifications and navigating bioinformatics terrain","author":"Flender","year":"2024","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.mcpro.2025.100971_bib28","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1038\/s41467-023-39425-1","article-title":"Molecular mechanism of phosphopeptide neoantigen immunogenicity","volume":"14","author":"Patskovsky","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.100971_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100823","article-title":"Innovations toward immunopeptidomics","volume":"23","author":"Abelin","year":"2024","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.mcpro.2025.100971_bib30","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.4049\/jimmunol.163.7.3812","article-title":"Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL","volume":"163","author":"Andersen","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.mcpro.2025.100971_bib31","doi-asserted-by":"crossref","first-page":"54160","DOI":"10.18632\/oncotarget.16952","article-title":"The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status","volume":"8","author":"Mohammed","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.mcpro.2025.100971_bib32","doi-asserted-by":"crossref","first-page":"14889","DOI":"10.1073\/pnas.0604045103","article-title":"Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy","volume":"103","author":"Zarling","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.100971_bib33","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.192.12.1755","article-title":"Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo","volume":"192","author":"Zarling","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mcpro.2025.100971_bib34","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.4049\/jimmunol.171.10.5287","article-title":"Tapasin is a facilitator, not an editor, of class I MHC peptide binding","volume":"171","author":"Zarling","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.mcpro.2025.100971_bib35","doi-asserted-by":"crossref","first-page":"203ra125","DOI":"10.1126\/scitranslmed.3006061","article-title":"MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia","volume":"5","author":"Cobbold","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mcpro.2025.100971_bib36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1158\/2326-6066.CIR-16-0280","article-title":"Identification of glycopeptides as posttranslationally modified neoantigens in leukemia","volume":"5","author":"Malaker","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.mcpro.2025.100971_bib37","doi-asserted-by":"crossref","first-page":"D512","DOI":"10.1093\/nar\/gku1267","article-title":"PhosphoSitePlus, 2014: mutations, PTMs and recalibrations","volume":"43","author":"Hornbeck","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcpro.2025.100971_bib38","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the universal protein knowledgebase in 2023","volume":"51","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcpro.2025.100971_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41587-019-0344-3","article-title":"The functional landscape of the human phosphoproteome","volume":"38","author":"Ochoa","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mcpro.2025.100971_bib40","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinforma. Oxf. Engl."},{"key":"10.1016\/j.mcpro.2025.100971_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002071","article-title":"HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy","volume":"9","author":"Marcu","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mcpro.2025.100971_bib42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13059-023-03029-1","article-title":"BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens","volume":"24","author":"Cuevas","year":"2023","journal-title":"Genome Biol."},{"key":"10.1016\/j.mcpro.2025.100971_bib43","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcpro.2025.100971_bib44","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nprot.2007.261","article-title":"Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips","volume":"2","author":"Rappsilber","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mcpro.2025.100971_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0021-9673(00)96972-3","article-title":"Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds","volume":"499","author":"Alpert","year":"1990","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.mcpro.2025.100971_bib46","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/jssc.200900476","article-title":"Hydrophilic interaction LC of peptides: columns comparison and clustering","volume":"33","author":"Van Dorpe","year":"2010","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.mcpro.2025.100971_bib47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jbbm.2004.01.006","article-title":"Peptide separation by hydrophilic-interaction chromatography: a review","volume":"60","author":"Yoshida","year":"2004","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.mcpro.2025.100971_bib48","article-title":"PNGaseF-generated N-glycans adduct onto peptides in the gas phase","author":"Rangel-Angarita","year":"2024","journal-title":"ChemRxiv"},{"key":"10.1016\/j.mcpro.2025.100971_bib49","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1073\/pnas.0607084104","article-title":"Analysis of phosphorylation sites on proteins from Saccharomyces cerevisiae by electron transfer dissociation (ETD) mass spectrometry","volume":"104","author":"Chi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.100971_bib50","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/nprot.2015.086","article-title":"Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry","volume":"10","author":"Abelin","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mcpro.2025.100971_bib53","doi-asserted-by":"crossref","first-page":"100112","DOI":"10.1016\/j.mcpro.2021.100112","article-title":"MHC phosphopeptides: promising targets for immunotherapy of cancer and other chronic diseases","volume":"20","author":"Mahoney","year":"2021","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.mcpro.2025.100971_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.723566","article-title":"Tumor infiltrating lymphocytes target HLA-I phosphopeptides derived from cancer signaling in colorectal cancer","volume":"12","author":"Penny","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcpro.2025.100971_bib55","series-title":"Phosphopeptides as Melanoma Vaccines","author":"Topalian","year":"2016"},{"key":"10.1016\/j.mcpro.2025.100971_bib56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/10826079708010641","article-title":"Immobilized iron (III) metal affinity chromatography for the separation of phosphorylated macromolecules: ligands and applications","volume":"20","author":"Holmes","year":"1997","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.mcpro.2025.100971_bib57","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1021\/ac202877y","article-title":"Advances in quantitative phosphoproteomics","volume":"84","author":"Nilsson","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcpro.2025.100971_bib58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/mas.20219","article-title":"Techniques for phosphopeptide enrichment prior to analysis by mass spectrometry","volume":"29","author":"Dunn","year":"2010","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.mcpro.2025.100971_bib59","series-title":"Critical Stability Constants","author":"Martell","year":"1974"},{"key":"10.1016\/j.mcpro.2025.100971_bib60","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1146\/annurev-biochem-060608-102511","article-title":"Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease","volume":"80","author":"Hart","year":"2011","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.mcpro.2025.100971_bib61","first-page":"5144","article-title":"The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene","volume":"58","author":"Hogan","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcpro.2025.100971_bib62","doi-asserted-by":"crossref","first-page":"10922","DOI":"10.1021\/jacs.5b06586","article-title":"Extended O-GlcNAc on HLA class-I-bound peptides","volume":"137","author":"Marino","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mcpro.2025.100971_bib63","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/cas.12884","article-title":"Dysregulation of protein methyltransferases in human cancer: an emerging target class for anticancer therapy","volume":"107","author":"Hamamoto","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.mcpro.2025.100971_bib64","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.3389\/fimmu.2019.02570","article-title":"Immunomodulatory effects of genetic alterations affecting the kynurenine pathway","volume":"10","author":"Boros","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcpro.2025.100971_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fimmu.2020.00055","article-title":"Activation of the kynurenine pathway in human malignancies can Be suppressed by the cyclin-dependent kinase inhibitor dinaciclib","volume":"11","author":"Riess","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcpro.2025.100971_bib66","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1074\/mcp.TIR119.001641","article-title":"Mass spectrometry based immunopeptidomics leads to robust predictions of phosphorylated HLA class I ligands","volume":"19","author":"Solleder","year":"2020","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.mcpro.2025.100971_bib67","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41587-022-01464-2","article-title":"Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors","volume":"41","author":"Kacen","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mcpro.2025.100971_bib68","article-title":"NetMHCphosPan - pan-specific prediction of MHC class I antigen presentation of phosphorylated ligands","volume":"1\u20132","author":"Refsgaard","year":"2021","journal-title":"ImmunoInformatics"},{"key":"10.1016\/j.mcpro.2025.100971_bib69","doi-asserted-by":"crossref","first-page":"D428","DOI":"10.1093\/nar\/gkac965","article-title":"The MHC Motif Atlas: a database of MHC binding specificities and ligands","volume":"51","author":"Tadros","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcpro.2025.100971_bib70","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1586\/erv.10.66","article-title":"MHC-peptide tetramers for the analysis of antigen-specific T cells","volume":"9","author":"Sims","year":"2010","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.mcpro.2025.100971_bib71","first-page":"7","article-title":"Phenotypic analysis of antigen-specific T lymphocytes","volume":"187","author":"Altman","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.mcpro.2025.100971_bib72","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1172\/JCI8476","article-title":"MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen","volume":"104","author":"Novak","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mcpro.2025.100971_bib73","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2019.07.009","article-title":"T-scan: a genome-wide method for the systematic discovery of T cell epitopes","volume":"178","author":"Kula","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.100971_bib74","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcpro.2025.100971_bib75","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/bio.2015.29031.hmm","article-title":"The genotype-tissue expression (GTEx) project","volume":"13","author":"Carithers","year":"2015","journal-title":"Biopreservation Biobanking"}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947625000696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947625000696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T15:36:15Z","timestamp":1757604975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947625000696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":73,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1535947625000696"],"URL":"https:\/\/doi.org\/10.1016\/j.mcpro.2025.100971","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Post-translationally Modified MHC Class I\u2013Associated Peptides as Potential Cancer Immunotherapeutic Targets","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcpro.2025.100971","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"100971"}}